Oral intake of Kluyveromyces marxianus B0399 plus Lactobacillus rhamnosus CECT 30579 to mitigate symptoms in COVID-19 patients: A randomized open label clinical trial.
Med Microecol
; 14: 100061, 2022 Dec.
Article
in En
| MEDLINE
| ID: mdl-36035620
ACE-2, angiotensin converting enzyme-2; CECT, spanish type culture collection; CFU, colony-forming unit; COPD, chronic obstructive pulmonary disease; COVID-19; COVID-19, coronavirus disease; CURB-65, pneumoniae severity score; DVT, deep vein thrombosis; HHU, home hospitalization unit; HT, HT:Hypertension; IBS, Intestine Bowel Syndrome; ICU, intensive care unit; Microbiome; Microbiota; PCR, polymerase chain reaction; Probiotics; RNA, ribonucleic adid; SARS-CoV-2; SD, standard deviation; SPSS, Statistical Package for Social Science
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Clinical_trials
/
Diagnostic_studies
Language:
En
Journal:
Med Microecol
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: